← All indications
Yellow Fever
An acute infectious disease primarily of the tropics, caused by a virus and transmitted to man by mosquitoes of the genera Aedes and Haemagogus. The severe form is characterized by fever, HEMOLYTIC JAUNDICE, and renal damage.
Drugs by status
Approved for this indication (1)
Phase 3 trials (11)
- pneumococcal 13-valent conjugate vaccine
- typhoid vi polysaccharide vaccine
- hepatitis a vaccine, inactivated
- inactivated japanese encephalitis vaccine
- live, attenuated, dengue serotype 1, 2, 3, 4 virus
- measles-rubella vaccine
- measles, mumps, and rubella vaccine
- meningococcal (groups A, C, Y, W) tetanus toxoid conjugate vaccine
- haemophilus influenzae type b conjugate vaccine
- acellular pertussis vaccine (including diptheria and tetanus toxoids)
- Bivalent group A and C meningococcal vaccine
Phase 1 trials (7)
Organizations
Organization Involved with Phase 4 Indications (13)
- Institut Pasteur
- Epicentre
- Pan American Health Organization
- Aarhus University
- University of Oxford
- Medical Research Council-UVRI Uganda Research Unit on AIDS
- Wellcome Trust
- Infectious Disease Institute, Kampala, Uganda
- Government of Brazil
- Government of Argentina
- Government of Uganda
- Centers for Disease Control and Prevention (CDC)
- Oswaldo Cruz Foundation
Organization Involved with Phase 3 Indications (6)
Organization Involved with Phase 2 Indications (8)
Organization Involved with Phase 1 Indications (5)
Organization Involved with Other Experimental Indications (3)